Voxzogo Unione Europea - danese - EMA (European Medicines Agency)

voxzogo

biomarin international limited - vosoritide - achondroplasia - narkotika til behandling af knoglesygdomme - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

Kimmtrak Unione Europea - danese - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastiske midler - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Arlevert 20+40 mg tabletter Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

arlevert 20+40 mg tabletter

hennig arzneimittel ag - cinnarizin, dimenhydrinat - tabletter - 20+40 mg

Lidokain "Aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte

laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml

Lidokain "Aguettant" 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "aguettant" 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte

laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 20 mg/ml

Morphine "Unimedic" 1 mg/ml injektionsvæske, opløsning Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

morphine "unimedic" 1 mg/ml injektionsvæske, opløsning

unimedic pharma ab - morphinhydrochlorid (trihydrate) - injektionsvæske, opløsning - 1 mg/ml

Yescarta Unione Europea - danese - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.